Chiffres calculés à partir des déclarations réglementaires officielles — .
Analystesobjectif 451.71 USD (+3%) · consensus 4.18/5 · 14 achat · 8 conserver · 0 vente
Détentioninitiés 0.19% · institutions 94.03% · vente à découvert 2.5% du flottant
En USD · au Oct 19, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de Elevance Health, Inc. uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Source des informations de marché · Oct 19, 2026
Périodes présentes dans les registres consultés. Elles ne certifient pas les dates juridiques de changement de nom.
Identité selon la SEC · Oct 19, 2026
Chronologie sur le marché · historique complet
17 achats1,830 ventes— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Kaye Mark | Autre | $1.6M | Taille inhabituelle | SEC |
| Wessling Erin M | Autre | $38.1K | SEC |
| Wessling Erin M | Autre | $105.8K | SEC |
| Craig Ryan R | Autre | $58.4K | SEC |
| PERU RAMIRO Ghistorique | Achat | $366.1K | conv 54Taille inhabituellePremier en 12 mois | SEC |
| BOUDREAUX GAILhistorique | Achat | $753.1K | conv 35 | SEC |
| BOUDREAUX GAILhistorique | Achat | $249.2K | conv 32 | SEC |
| Penczek Ronald W | Vente | $148.8K | SEC |
| Dixon Robert L JR | Vente | $60.7K | SEC |
| Penczek Ronald W | ExerciceD (dérivé) | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Penczek Ronald W | Vente | $617.2K | SEC |
| Penczek Ronald W | Exercice | $177.4K | SEC |
| Penczek Ronald W | ExerciceD (dérivé) | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Penczek Ronald W | Exercice | $273.2K | Taille inhabituelle | SEC |
| COLLIS STEVEN H | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| HAY LEWIS III | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Neri Antonio F | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Dixon Robert L JR | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| STRABLE-SOETHOUT DEANNA D | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| SCHULMAN AMY Whistorique | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Schneider Ryan M. | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| DeVore Susan D. | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| PERU RAMIRO Ghistorique | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |
| Jallal Bahija | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |